FGP
PRVA icon

Freestone Grove Partners’s Privia Health PRVA Stock Holding History

Freestone Grove Partners’s Portfolio PRVA Stock Details PRVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$17.6M Sell
685,489
-153,985
-18% -$3.57M 0.11% 222
2026
Q1 		$17.3M Sell
839,474
-373,868
-31% -$8.43M 0.12% 227
2025
Q4 		$28.8M Buy
1,213,342
+350,194
+41% +$8.52M 0.21% 162
2025
Q3 		$21.5M Buy
863,148
+322,426
+60% +$6.94M 0.16% 195
2025
Q2 		$12.4M Buy
+540,722
New +$12.5M 0.09% 257

Other funds holding PRVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DCP
Durable Capital Partners Bethesda, Maryland $10.3B AUM 29.04% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
RF
Rubicon Founders Nashville, Tennessee $196M AUM 53.12% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VBA
Van Berkom & Associates Montreal, Quebec, Canada $3.1B AUM 12.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

Freestone Grove Partners's PRVA Position: Q2 2026 in Review

Freestone Grove Partners reduced its Privia Health (PRVA) stake by 18% in Q2 2026, selling an estimated $3.57M and leaving 685,489 shares worth $17.6M. The position accounts for 0.11% of the portfolio, ranked #222.

Freestone Grove Partners first reported a position in PRVA in Q2 2025 and has held it in 5 quarters since. The position peaked at $28.8M in Q4 2025. 302 funds tracked by Wall St. Rank hold PRVA as of Q2 2026.

  • Freestone Grove Partners held 685,489 shares of Privia Health worth $17.6M as of Q2 2026.
  • Freestone Grove Partners sold 153,985 Privia Health shares in Q2 2026, an estimated $3.57M.
  • Privia Health made up 0.11% of Freestone Grove Partners's portfolio in Q2 2026, its #222 holding.
  • Freestone Grove Partners first reported a position in Privia Health in Q2 2025 and has held it in 5 quarters since.
  • Freestone Grove Partners's Privia Health position peaked at $28.8M in Q4 2025.
  • 302 funds tracked by Wall St. Rank held Privia Health as of Q2 2026.

Based on Freestone Grove Partners's 13F filing for Q2 2026, filed 14 Aug 2026.